Genprex Announces $10 Million Private Placement

AUSTIN, Texas, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today th... Biopharmaceuticals, Oncology, Venture Capital Genprex, Oncoprex, immunogene therapy, NSCLC
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news